Invivyd (IVVD) Assets Growth (1y) (2021 - 2025)
Invivyd (IVVD) Assets Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Invivyd | 104.14 Mn | -122.55 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 113.78% |
| Sep 30, 2025 | -14.06% |
| Jun 30, 2025 | -49.74% |
| Mar 31, 2025 | -51.85% |
| Dec 31, 2024 | -43.49% |
| Sep 30, 2024 | -41.10% |
| Jun 30, 2024 | -43.77% |
| Mar 31, 2024 | -38.54% |
| Dec 31, 2023 | -40.19% |
| Sep 30, 2023 | -35.28% |
| Jun 30, 2023 | -34.91% |
| Mar 31, 2023 | -36.98% |
| Dec 31, 2022 | -38.21% |
| Sep 30, 2022 | -38.11% |
| Jun 30, 2022 | 21.76% |
| Dec 31, 2021 | 428.27% |